The perceived barriers and facilitators to implementation of early mobilisation within a multicentre, phase 3 randomised controlled trial: A qualitative process evaluation study

Process Evaluation ◽

Controlled Trial ◽

Evaluation Study ◽

Perceived Barriers ◽

Early Mobilisation ◽

Phase 3 ◽

Multicentre Phase ◽

Erratum to: Evaluating the PRASE patient safety intervention - a multi-centre, cluster trial with a qualitative process evaluation: study protocol for a randomised controlled trial

Trials ◽

10.1186/s13063-016-1655-z ◽

2016 ◽

Vol 17 (1) ◽

Cited By ~ 1

Author(s):

Laura Sheard ◽

Jane O’Hara ◽

Gerry Armitage ◽

John Wright ◽

Kim Cocks ◽

...

Keyword(s):

Patient Safety ◽

Process Evaluation ◽

Study Protocol ◽

Controlled Trial ◽

Evaluation Study ◽

Cluster Trial ◽

Safety Intervention ◽

Evaluating the PRASE patient safety intervention - a multi-centre, cluster trial with a qualitative process evaluation: study protocol for a randomised controlled trial

Trials ◽

10.1186/1745-6215-15-420 ◽

2014 ◽

Vol 15 (1) ◽

Cited By ~ 19

Author(s):

Laura Sheard ◽

◽

Jane O’Hara ◽

Gerry Armitage ◽

John Wright ◽

...

Keyword(s):

Patient Safety ◽

Process Evaluation ◽

Study Protocol ◽

Controlled Trial ◽

Evaluation Study ◽

Cluster Trial ◽

Safety Intervention ◽

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

The Lancet Oncology ◽

10.1016/s1470-2045(17)30404-7 ◽

2017 ◽

Vol 18 (7) ◽

pp. 929-945 ◽

Cited By ~ 29

Author(s):

David Cameron ◽

James P Morden ◽

Peter Canney ◽

Galina Velikova ◽

Robert Coleman ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Therapy ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

Multicentre Phase ◽

Parents’ and clinicians’ views of an interactive booklet about respiratory tract infections in children: a qualitative process evaluation of the EQUIP randomised controlled trial

BMC Family Practice ◽

10.1186/1471-2296-14-182 ◽

2013 ◽

Vol 14 (1) ◽

Cited By ~ 17

Author(s):

Nick A Francis ◽

Rhiannon Phillips ◽

Fiona Wood ◽

Kerry Hood ◽

Sharon Simpson ◽

...

Keyword(s):

Respiratory Tract ◽

Process Evaluation ◽

Respiratory Tract Infections ◽

Controlled Trial ◽

Randomised Controlled ◽

Tract Infections

Qualitative methods in a randomised controlled trial: the role of an integrated qualitative process evaluation in providing evidence to discontinue the intervention in one arm of a trial of a decision support tool

BMJ Quality & Safety ◽

10.1136/qshc.2006.018499 ◽

2007 ◽

Vol 16 (3) ◽

pp. 224-229 ◽

Cited By ~ 42

Author(s):

M J Murtagh ◽

R G Thomson ◽

C R May ◽

T Rapley ◽

B R Heaven ◽

...

Keyword(s):

Decision Support ◽

Qualitative Methods ◽

Process Evaluation ◽

Controlled Trial ◽

Decision Support Tool ◽

Support Tool ◽

Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(18)30036-6 ◽

2018 ◽

Vol 6 (5) ◽

pp. 382-391 ◽

Cited By ~ 12

Author(s):

Sobha Sivaprasad ◽

Joana C Vasconcelos ◽

A Toby Prevost ◽

Helen Holmes ◽

Philip Hykin ◽

...

Keyword(s):

Clinical Efficacy ◽

Macular Oedema ◽

Dark Adaptation ◽

Controlled Trial ◽

Diabetic Macular Oedema ◽

Efficacy And Safety ◽

Phase 3 ◽

Multicentre Phase ◽

Faculty Opinions recommendation of Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1166102.628092 ◽

2009 ◽

Author(s):

Jim Orr ◽

Fadi Abu Shahin

Keyword(s):

Ovarian Cancer ◽

Controlled Trial ◽

Advanced Ovarian Cancer ◽

Open Label ◽

Phase 3 ◽

Dose Dense ◽

Faculty Opinions recommendation of Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13827960.15267062 ◽

2012 ◽

Author(s):

Weijing Sun ◽

Davendra Sohal

Keyword(s):

Gastric Cancer ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

D2 Gastrectomy ◽

Faculty Opinions recommendation of Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718302523.793494710 ◽

2014 ◽

Author(s):

Anthony Harries

Keyword(s):

Clinical Outcomes ◽

Antiretroviral Treatment ◽

Controlled Trial ◽

Phase 3 ◽

Delayed Initiation ◽

Randomised Controlled ◽

Hiv 1

Faculty Opinions recommendation of Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.9952956.10680055 ◽

2011 ◽

Author(s):

Jacques Bernier

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Controlled Trial ◽

Phase 3 ◽

Conventional Radiotherapy ◽

Intensity Modulated ◽

Parotid Sparing ◽